17.6% Return Seen to Date on SmarTrend PharMerica Call (PMC)
Comtex SmarTrend(R) - Wed Dec 24, 11:13AM CST
SmarTrend identified a Downtrend for PharMerica (NYSE
PMC: 20.76 (-0.13)
Shares of PMC Down 16.5% Since Downtrend Call on Shares
Comtex SmarTrend(R) - Wed Dec 10, 9:31AM CST
SmarTrend identified a Downtrend for PharMerica (NYSE
PMC: 20.76 (-0.13)
Omnicare Rewards Shareholders with 10% Dividend Raise - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Dec 08, 4:50PM CST
Healthcare services company, Omnicare (OCR), recently raised its quarterly dividend by 10% to 22 cents per share.
PMC: 20.76 (-0.13), OCR: 73.20 (+0.33), MCK: 209.79 (+0.58), CAH: 82.07 (+0.15)
PharMerica Has Returned 16.9% Since SmarTrend Recommendation (PMC)
Comtex SmarTrend(R) - Tue Dec 02, 5:24PM CST
SmarTrend identified a Downtrend for PharMerica (NYSE
PMC: 20.76 (-0.13)
Onco360 Selected by Pfizer as Limited Distribution Pharmacy Provider; Expands Onco360's Industry-Leading Portfolio to Nearly 40 Products
Business Wire - Mon Dec 01, 3:15PM CST
Onco360, one of the nation's largest independent providers of Oncology Pharmacy services, today announced that it has been selected as a limited distribution pharmacy network participant by Pfizer Inc. ("Pfizer"
PMC: 20.76 (-0.13)
Earnings Flashback: Since Reporting Quarterly Results 2 Weeks Ago PharMerica Is Down 14.2% (PMC)
Comtex SmarTrend(R) - Mon Nov 24, 7:19AM CST
18 days ago, on November 6th, 2014, PharMerica (NYSE
PMC: 20.76 (-0.13)
Post Earnings Update: PharMerica Has Sunk 8.8% Lower in Past Week (PMC)
Comtex SmarTrend(R) - Mon Nov 17, 8:34AM CST
When PharMerica (NYSE
PMC: 20.76 (-0.13)
NYSE stocks posting largest percentage decreases
AP - Thu Nov 13, 12:28PM CST
NEW YORK (AP) — A look at the 10 biggest percentage decliners on New York Stock Exchange at 1 p.m.:
PMC: 20.76 (-0.13), RCAP: 11.23 (+0.26), W: 20.44 (-0.35), RICE: 22.41 (-0.33), RESI: 18.72 (+0.12), HP: 67.25 (-0.66), WAC: 16.73 (-0.15), TAHO: 13.31 (+0.56), ZEP: 15.59 (-0.01), CRK: 7.01 (-0.20), THO.TO: 15.46 (+0.63)
Pharmerica (PMC) Upgraded From Hold to Buy
at The Street - Wed Nov 12, 8:35AM CST
Pharmerica (PMC) has been upgraded by TheStreet Ratings from Hold to Buy with a ratings score of B.
PMC: 20.76 (-0.13)
PharMerica's (PMC) CEO Gregory Weishar on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Nov 06, 3:20PM CST
PMC: 20.76 (-0.13)
PharMerica (PMC) Q3 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Thu Nov 06, 8:55AM CST
PMC: 20.76 (-0.13)
PharMerica beats by $0.05, beats on revenue
Seeking Alpha - at Seeking Alpha - Thu Nov 06, 7:25AM CST
PMC: 20.76 (-0.13)
PharMerica Reports Third Quarter 2014 Results
Business Wire - Thu Nov 06, 7:21AM CST
--Successfully Executing Strategic and Operational Initiatives to Drive Long-Term Growth and Value Creation
PMC: 20.76 (-0.13)
PharMerica to Present at the Credit Suisse 2014 Healthcare Conference
Business Wire - Tue Oct 28, 9:20AM CDT
PharMerica Corporation (NYSE: PMC), a national provider of institutional pharmacy, specialty home infusion, and oncology pharmacy services, today announced that David Froesel, Executive Vice President, Chief Financial Officer and Treasurer, will make a presentation regarding the Company at the Credit Suisse 2014 Healthcare Conference in Phoenix, Arizona, on Tuesday, November 11, 2014, at 1:30 p.m. Mountain Time (3:30 p.m. Eastern Time).
PMC: 20.76 (-0.13)
Omnicare Beats on Q3 Earnings and Sales, Outlook Positive - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Oct 27, 11:40AM CDT
Omnicare Inc. (OCR) reported better-than-expected third quarter 2014 results.
PMC: 20.76 (-0.13), OCR: 73.20 (+0.33), CRL: 63.59 (+0.33), ICLR: 52.66 (+0.72)
Onco360 Appoints Paul Jardina as President and Chief Executive Officer
Business Wire - Mon Oct 27, 8:00AM CDT
Onco360, one of the nation's largest independent providers of oncology pharmacy services, today announced that Paul Jardina has been named President and Chief Executive Officer.
PMC: 20.76 (-0.13)
PharMerica Corporation Announces Third Quarter 2014 Earnings Call and Webcast
Business Wire - Mon Oct 13, 10:57AM CDT
PharMerica Corporation (NYSE
PMC: 20.76 (-0.13)
PharMerica closes Millennium Pharmacy Systems' acquisition, increasing its footprint in the Mid-Atlantic region
M2 - Mon Sep 29, 6:04AM CDT
Oncology pharmacy PharMerica (NYSE
PMC: 20.76 (-0.13)